Effect of saponin and filipin on antagonist binding to AT1 receptors in intact cells

Biochemical Pharmacology

Volumn 67, Issue 8, 2004, Pages 1601-1606

  Verheijen, Ilse ^a   Tourlousse, Dieter ^a   Vanderheyden, Patrick M L ^a   De Backer, Jean Paul ^a   Vauquelin, Georges ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Ang II; Angiotensin II; Angiotensin II receptor type 1; AT1; Chinese Hamster Ovary cells expressing human AT 1 receptors; CHO hAT1 cells; G protein coupled receptor; GPCR; S adenosylmethionine; SAM

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; CANDESARTAN; FILIPIN; LOSARTAN; SAPONIN; TRITIUM; VALSARTAN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHINESE HAMSTER; CHO CELL; CONTROLLED STUDY; DRUG PENETRATION; DRUG RECEPTOR BINDING; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DRUG INTERACTIONS; FEMALE; FILIPIN; HUMANS; KINETICS; RADIOLIGAND ASSAY; RECEPTOR, ANGIOTENSIN, TYPE 1; SAPONINS; TETRAZOLES; TRANSFECTION;

EID: 1642313539     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.01.004     Document Type: Article

References (37)

1. Vanderheyden P.M., Fierens F.L., De Backer J., Vauquelin G. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors. Biochem. Pharmacol. 59(8):2000;927-935.
2. Vauquelin G., Morsing P., Fierens F.L., De Backer J.P., Vanderheyden P.M. A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists. Biochem. Pharmacol. 61(3):2001;277-284.
3. 1 receptor-transfected Chinese hamster ovary cells Eur. J. Pharmacol. 367(2/3):1999;413-422.
4. Fierens F.L., Vanderheyden P.M., Roggeman C., Vande Gucht P., De Backer J.P., Vauquelin G. Distinct binding properties of the AT(1) receptor antagonist [(3)H]candesartan to intact cells and membrane preparations. Biochem. Pharmacol. 63(7):2002;1273-1279.
5. Vareesangthip K., Thomas T.H., Tong P., Wilkinson R. Erythrocyte membrane fluidity in adult polycystic kidney disease: difference between intact cells and ghost membranes. Eur. J. Clin. Invest. 26(2):1996;171-173.
6. 2. J. Biol. Chem. 276(25):2001;22722-22731.
7. Gimpl G., Burger K., Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry. 36(36):1997;10959-10974.
8. Sooksawate T., Simmonds M.A. Effects of membrane cholesterol on the sensitivity of the GABA(A) receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology. 40(2):2001;178-184.
9. Pang L., Graziano M., Wang S. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry. 38(37):1999;12003-12011.
10. Barabe F., Pare G., Fernandes M.J., Bourgoin S.G., Naccache P.H. Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. J. Biol. Chem. 277(16):2002;13473-13478.
11. Pike L.J. Lipid rafts: bringing order to chaos. J. Lipid Res. 44:2003;655-667.
12. Armah C.N., Mackie A.R., Roy C., Price K., Osbourn A.E., Bowyer P., Ladha S. The membrane-permeabilizing effect of avenacin A-1 involves the reorganization of bilayer cholesterol. Biophys. J. 76:1999;281-290.
13. McGookey D.J., Fagerberg K., Anderson R.G. Filipin-cholesterol complexes form in uncoated vesicle membrane derived from coated vesicles during receptor-mediated endocytosis of low density lipoprotein. J. Cell Biol. 96(5):1983;1273-1278.
14. Robinson J.M., Karnovsky M.J. Evaluation of the polyene antibiotic filipin as a cytochemical probe for membrane cholesterol. J. Histochem. Cytochem. 28:1980;161-168.
15. 1 receptors. Br. J. Pharmacol. 126(4):1999;1057- 1065.
16. Le M.T., Vanderheyden P.M., Szaszak M., Hunyady L., Tersemans V., Vauquelin G. Peptide and nonpeptide antagonist interaction with constitutively active human ATI receptors. Biochem. Pharmacol. 65:2003;1329-1338.
17. 1-receptor antagonists. J. Renin Angiotensin Aldosterone Syst. 2:2001;S24-S31.
18. Fierens F.L., Vanderheyden P.M., Gaborik Z., Minh T.L., Backer J.P., Hunyady L.et al. Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists. J. Renin Angiotensin Aldosterone Syst. 1(3):2000;283-288.
19. Ishida H., Hirota Y., Nakazawa H. Effect of sub-skinning concentrations of saponin on intracellular Ca2+ and plasma membrane fluidity in cultured cardiac cells. Biochim. Biophys Acta. 1145(1):1993;58-62.
20. Miyamoto A., Kowatch M.A., Roth G.S. Similar effects of saponin treatment and aging on coupling of alpha 1-adrenergic receptor-G-protein. Exp. Gerontol. 28(4/5):1993;349-359.
21. Kowatch M.A., Roth G.S. Effect of specific membrane perturbations on alpha 1-adrenergic and muscarinic-cholinergic signal transduction in rat parotid cell aggregates. Life Sci. 55(25/26):1994;2003-2010.
22. Burger K., Gimpl G., Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol. Life Sci. 57(11):2000;1577-1592.
23. Awasthi-Kalia M., Schnetkamp P.P., Deans J.P. Differential effects of filipin and methyl-beta-cyclodextrin on B cell receptor signaling. Biochem. Biophys. Res. Commun. 287(1):2001;77-82.
24. Vance D.E., de Kruijff B. The possible functional significance of phosphatidylethanolamine methylation. Nature. 288(5788):1980;277-279.
25. Cimino M., Vantini G., Algeri S., Curatola G., Pezzoli C., Stramentinoli G. Age-related modification of dopaminergic and beta-Adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. Life Sci. 34(21):1984;2029-2039.
26. Ishizaka N., Griendling K.K., Lassegue B., Alexander R.W. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension. 32(3):1998;459-466.
27. Gaborik Z., Szaszak M., Szidonya L., Balla B., Paku S., Catt K.J.et al. Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol. Pharmacol. 59(2):2001;239-247.
28. Wyse B.D., Prior I.A., Qian H., Morrow I.C., Nixon S., Muncke C.et al. Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J. Biol. Chem. 278(26):2003;23738- 23746.
29. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:1998;111-136.
30. Anderson R.G. The caveolae membrane system. Annu. Rev. Biochem. 67:1998;199-225.
31. Chang W.J., Rothberg K.G., Kamen B.A., Anderson R.G. Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Biol. 118(1):1992;63-69.
32. Fielding C.J., Fielding P.E. Cholesterol and caveolae: structural and functional relationships. Biochim. Biophys Acta. 1529(1-3):2000;210-222.
33. Parpal S., Karlsson M., Thorn H., Stralfors P. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J. Biol. Chem. 276(13):2001;9670-9678.
34. Hailstones D., Sleer L.S., Parton R.G., Stanley K.K. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J. Lipid Res. 39(2):1998;369-379.
35. Furuchi T., Anderson R.G. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273(33):1998;21099-21104.
36. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell. 68(4):1992;673-682.
37. Hara M., Tozawa F., Itazaki K., Mihara S., Fujimoto M. Endothelin ET(B) receptors show different binding profiles in intact cells and cell membrane preparations. Eur. J. Pharmacol. 345(3):1998;339-342.